Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Sell
4,323
-35,270
-89% -$4.63M ﹤0.01% 877
2025
Q4
$5.39M Buy
39,593
+32,635
+469% +$4.69M 0.02% 508
2025
Q3
$1.03M Buy
+6,958
New +$965K ﹤0.01% 849
2025
Q2
Sell
-1,968
Closed -$235K 741
2025
Q1
$235K Sell
1,968
-514
-21% -$63.7K ﹤0.01% 633
2024
Q4
$288K Buy
2,482
+927
+60% +$117K ﹤0.01% 632
2024
Q3
$210K Sell
1,555
-111
-7% -$14.8K ﹤0.01% 763
2024
Q2
$226K Sell
1,666
-5,685
-77% -$773K ﹤0.01% 851
2024
Q1
$950K Sell
7,351
-14,705
-67% -$1.78M ﹤0.01% 575
2023
Q4
$2.52M Sell
22,056
-834
-4% -$83.2K 0.01% 482
2023
Q3
$2.08M Sell
22,890
-1,430
-6% -$147K 0.01% 495
2023
Q2
$2.74M Sell
24,320
-5,139
-17% -$543K 0.02% 420
2023
Q1
$3.08M Sell
29,459
-22,425
-43% -$2.34M 0.02% 390
2022
Q4
$5.74M Sell
51,884
-1,272
-2% -$133K 0.03% 339
2022
Q3
$4.64M Sell
53,156
-15,385
-22% -$1.4M 0.02% 396
2022
Q2
$5.36M Sell
68,541
-43,526
-39% -$3.59M 0.02% 464
2022
Q1
$9.55M Buy
112,067
+76,902
+219% +$7.37M 0.04% 309
2021
Q4
$4.22M Buy
+35,165
New +$4.36M 0.02% 334
2021
Q3
Sell
-48,720
Closed -$5.84M 808
2021
Q2
$5.84M Buy
+48,720
New +$5.56M 0.04% 307
2021
Q1
Sell
-18,152
Closed -$1.85M 623
2020
Q4
$1.85M Buy
18,152
+4,837
+36% +$455K 0.02% 316
2020
Q3
$1.12M Buy
+13,315
New +$1.04M 0.01% 333
2020
Q1
Sell
-7,680
Closed -$605K 615
2019
Q4
$605K Buy
+7,680
New +$598K 0.01% 394
2018
Q3
Sell
-21,337
Closed -$1.44M 494
2018
Q2
$1.44M Buy
+21,337
New +$1.55M 0.01% 221
2016
Q3
Sell
-13,100
Closed -$585K 413
2016
Q2
$585K Buy
+13,100
New +$569K 0.01% 276

Other funds holding XYL

Ray Dalio's XYL Position: Q1 2026 in Review

Ray Dalio reduced its Xylem (XYL) stake by 89% in Q1 2026, selling an estimated $4.63M and leaving 4,323 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #877.

Ray Dalio first reported a position in XYL in Q2 2016 and has held it in 23 quarters since. The position peaked at $9.55M in Q1 2022. 1,109 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Ray Dalio held 4,323 shares of Xylem worth $517K as of Q1 2026.
  • Ray Dalio sold 35,270 Xylem shares in Q1 2026, an estimated $4.63M.
  • Xylem made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #877 holding.
  • Ray Dalio first reported a position in Xylem in Q2 2016 and has held it in 23 quarters since.
  • Ray Dalio's Xylem position peaked at $9.55M in Q1 2022.
  • 1,109 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.